Enhanced response to repeated d-amphetamine challenge: Evidence for behavioral sensitization in humans

被引:112
|
作者
Strakowski, SM
Sax, KW
Setters, MJ
Keck, PE
机构
[1] Div. of Psychotic Disorders Research, Department of Psychiatry, Univ. of Cincinnati Coll. of Med., Cincinnati, OH
[2] Department of Psychiatry, Univ. of Cincinnati Coll. of Med., Cincinnati, OH 45267-0559
关键词
behavioral sensitization; d-amphetamine; human volunteers; rating scales; eye blinks;
D O I
10.1016/0006-3223(95)00497-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Behavioral sensitization is the process whereby intermittent stimulant exposure produces a time-dependent, enduring, and progressively more robust behavioral response. This process serves as an important model of neural plasticity and has also been proposed as a model for a variety of psychiatric syndromes; however, there are no published controlled studies of behavioral sensitization in human subjects. The authors report results from a double-blind, placebo-controlled study of repeated d-amphetamine challenges in a sample of normal human volunteers. Eleven consecutively recruited normal volunteers participated in this 4-day protocol. Each subject received two daily doses of d-amphetamine (0.25 mg/kg) separated by 48 hours that alternated with two daily doses of matched placebo. Symptoms (activity/energy level, mood, rate, and amount of speech) and eye-blink rates were measured hourly for 5 hours following drug administration. All four measures demonstrated significantly enhanced increases following the second amphetamine dose as compared to the first amphetamine dose and both placebo conditions. These findings suggest that behavioral sensitization is measurable in human subjects. (C) 1996 Society of Biological Psychiatry.
引用
收藏
页码:872 / 880
页数:9
相关论文
共 50 条
  • [1] Progressive behavioral response to repeated d-amphetamine challenge: Further evidence for sensitization in humans
    Strakowski, SM
    Sax, KW
    BIOLOGICAL PSYCHIATRY, 1998, 44 (11) : 1171 - 1177
  • [2] Enhanced behavioral response to repeated d-amphetamine and personality traits in humans
    Sax, KW
    Strakowski, SM
    BIOLOGICAL PSYCHIATRY, 1998, 44 (11) : 1192 - 1195
  • [3] Lack of enhanced response to repeated d-amphetamine challenge in first-episode psychosis: Implications for a sensitization model of psychosis in humans
    Strakowski, SM
    Sax, KW
    Setters, MJ
    Stanton, SP
    Keck, PE
    BIOLOGICAL PSYCHIATRY, 1997, 42 (09) : 749 - 755
  • [4] Subjective and behavioral effects of repeated d-amphetamine in humans
    Wachtel, SR
    de Wit, H
    BEHAVIOURAL PHARMACOLOGY, 1999, 10 (03): : 271 - 281
  • [5] Behavioral measures of sensitization to repeated d-amphetamine: Preliminary data on sex differences in healthy humans
    Weidenauer, A.
    Bauer, M.
    Bartova, L.
    Sauerzopf, U.
    Praschak-Rieder, N.
    Pfaff, S.
    Nics, L.
    Phillippe, C.
    Wadsak, W.
    Mitterhauser, M.
    Kasper, S.
    Willeit, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S265 - S265
  • [6] Sensitization to d-amphetamine after its repeated administration: evidence in EEG and behaviour
    Stahl, D
    Ferger, B
    Kuschinsky, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (03) : 335 - 340
  • [7] Sensitization to d-amphetamine after its repeated administration: evidence in EEG and behaviour
    D. Stahl
    B. Ferger
    K. Kuschinsky
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1997, 356 : 335 - 340
  • [8] Human response to repeated low-dose d-amphetamine: Evidence for behavioral enhancement and tolerance
    Strakowski, SM
    Sax, KW
    Rosenberg, HL
    DelBello, MP
    Adler, CM
    NEUROPSYCHOPHARMACOLOGY, 2001, 25 (04) : 548 - 554
  • [9] Human Response to Repeated Low-Dose d-Amphetamine: Evidence for Behavioral Enhancement and Tolerance
    Stephen M Strakowski
    Kenji W Sax
    H Lee Rosenberg
    Melissa P DelBello
    Caleb M Adler
    Neuropsychopharmacology, 2001, 25 : 548 - 554
  • [10] Alprazolam attenuates the behavioral effects of D-amphetamine in humans
    Rush, CR
    Stoops, WW
    Wagner, FP
    Hays, LR
    Glaser, PEA
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (04) : 410 - 420